Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1]
Lavanchy D..
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures..
J Viral Hepat. , 11 (2004), pp. 97-107
[2]
Bosch FX, Ribes J, Cleries R, Diaz M..
Epidemiology of hepatocellular carcinoma..
Clin Liver Dis. , 9 (2005), pp. 191-211
[3]
Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E..
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients..
Am J Gastroenterol. , 97 (2002), pp. 2886-95
[4]
Fontana RJ..
Management of patients with decompensated HBV cirrhosis..
Semin Liver Dis. , 23 (2003), pp. 89-100
[5]
Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al..
Lamivudine for patients with chronic hepatitis B and advanced liver disease..
N Engl J Med. , 351 (2004), pp. 1521-31
[6]
Fontana RJ, Keeffe EB, Carey W, Fried M, Reddy R, Kowdley KV, et al..
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B..
Liver Transpl. , 8 (2002), pp. 433-9
[7]
McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, Mc-Cullough CS, Dickson RC, et al..
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization..
Transplantation. , 61 (1996), pp. 1358-64
[8]
Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Bernardi-Venon W, et al..
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence..
Liver Transpl. , 11 (2005), pp. 402-9
[9]
Vargas HE, Dodson FS, Rakela J..
A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002..
Liver Transpl. , 8 (2002), pp. 2-9
[10]
Lampertico P, Vigano M, Manenti E, Iavarone M, Sablon E, Colombo M..
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients..
Gastroenterology. , 133 (2007), pp. 1445-51
[11]
Fung SK, Lok AS..
Management of patients with hepatitis B virus-induced cirrhosis..
J Hepatol. , 42 (2005), pp. S54-S64
[12]
Perrillo RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, et al..
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B..
Hepatology. , 33 (2001), pp. 424-32
[13]
Yao FY, Terrault NA, Freise C, Maslow L, Bass NM..
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort..
Hepatology. , 34 (2001), pp. 411-6
[14]
Villeneuve JP, Condreay LD, Willems B, Pomier-Layrargues G, Fenyves D, Bilodeau M, et al..
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B..
Hepatology. , 31 (2000), pp. 207-10
[15]
Fontana RJ, Hann HW, Perrillo RP, Vierling JM, Wright T, Rakela J, et al..
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy..
Gastroenterology. , 123 (2002), pp. 719-27
[16]
Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, et al..
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients..
Hepatology. , 38 (2003), pp. 1419-27
[17]
Schiff E, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, et al..
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results..
Liver Transpl. , 13 (2007), pp. 349-60
[18]
Fung J, Lai CL, Yuen JC, Wong DK, Tanaka Y, Mizokami M, et al..
Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population..
Antivir Ther. , 12 (2007), pp. 41-6
[19]
Van Bommel F, Wunsche T, Mauss S, Reinke P, Bergk A, Schurmann D, et al..
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection..
Hepatology. , 40 (2004), pp. 1421-5
[20]
Neff GW, Nery J, Lau DT, OBrien CB, Duncan R, Shire NJ, et al..
Tenofovir therapy for lamivudine resistance following liver transplantation..
Ann Pharmacother. , 38 (2004), pp. 1999-2004
